{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:58:34Z","timestamp":1791219514871,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1998,8,1]],"date-time":"1998-08-01T00:00:00Z","timestamp":901929600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[1998,8]]},"DOI":"10.1038\/1258","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T08:34:58Z","timestamp":1027672498000},"page":"371-374","source":"Crossref","is-referenced-by-count":50,"title":["A retinoblastoma-binding protein that affects cell-cycle control and confers transforming ability"],"prefix":"10.1038","volume":"19","author":[{"given":"Joseph T.","family":"Woitach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghuang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Hua","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snorri S.","family":"Thorgeirsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFng0898_371_CR1","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1126\/science.1659741","volume":"254","author":"RA Weinberg","year":"1991","unstructured":"Weinberg, R.A. Tumor suppressor genes. Science 254, 1138\u2013 1146 (1991).","journal-title":"Science"},{"key":"BFng0898_371_CR2","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1126\/science.6336308","volume":"219","author":"WF Benedict","year":"1983","unstructured":"Benedict, W.F. Patient with 13 chromosome deletion: evidence that the retinoblastoma gene is a recessive cancer gene. Science 219, 973\u2013 975 (1983).","journal-title":"Science"},{"key":"BFng0898_371_CR3","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1126\/science.3388033","volume":"241","author":"EY Lee","year":"1988","unstructured":"Lee, E.Y. et al. Inactivation of the retinoblastoma susceptibility gene in human breast cancers . Science 241, 218\u2013221 (1988).","journal-title":"Science"},{"key":"BFng0898_371_CR4","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1073\/pnas.87.7.2775","volume":"87","author":"JM Horowitz","year":"1990","unstructured":"Horowitz, J.M. et al. Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proc. Natl Acad. Sci. USA 87, 2775\u20132779 (1990).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFng0898_371_CR5","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.2300823","volume":"247","author":"R Bookstein","year":"1990","unstructured":"Bookstein, R., Shew, J.Y., Chen, P.L., Scully, P. & Lee, W.H. Suppression of tumorigenicity human prostate carcinoma cells by replacing a mutated RB gene. Science 247, 712\u2013715 (1990).","journal-title":"Science"},{"key":"BFng0898_371_CR6","first-page":"471","volume":"3","author":"J Yokota","year":"1988","unstructured":"Yokota, J. et al. Altered expression of the retinoblastoma (RB) gene in small-cell carcinoma of the lung. Oncogene 3, 471\u2013 475 (1988).","journal-title":"Oncogene"},{"key":"BFng0898_371_CR7","first-page":"445","volume":"6","author":"DJ Venter","year":"1991","unstructured":"Venter, D.J. et al. Retinoblastoma gene deletions in human glioblastomas. Oncogene 6, 445\u2013448 ( 1991).","journal-title":"Oncogene"},{"key":"BFng0898_371_CR8","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1182\/blood.V75.3.730.730","volume":"3","author":"J Cheng","year":"1990","unstructured":"Cheng, J. et al. Homozygous deletion of the retinoblastoma gene in an acute lymphoblastic leukemia (T) cell line. Blood 3, 730\u2013 735 (1990).","journal-title":"Blood"},{"key":"BFng0898_371_CR9","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1126\/science.3201247","volume":"242","author":"H-JS Huang","year":"1988","unstructured":"Huang, H.-J.S. et al. Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science 242, 1563\u2013 1566 (1988).","journal-title":"Science"},{"key":"BFng0898_371_CR10","doi-asserted-by":"publisher","first-page":"5257","DOI":"10.1073\/pnas.88.12.5257","volume":"88","author":"R Takahashi","year":"1991","unstructured":"Takahashi, R. et al. The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells. Proc. Natl Acad. Sci. USA 88, 5257\u20135261 (1991).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFng0898_371_CR11","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1101\/gad.6.6.953","volume":"6","author":"X-Q Qin","year":"1992","unstructured":"Qin, X.-Q., Chittenden, T., Livingston, D.M. & Kaelin, W.G. Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev. 6, 953\u2013964 ( 1992).","journal-title":"Genes Dev"},{"key":"BFng0898_371_CR12","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/0092-8674(91)90181-W","volume":"67","author":"DW Goodrich","year":"1991","unstructured":"Goodrich, D.W., Wang, N.P., Qian, Y.W., Lee, E.Y. & Lee, W.H. The retinoblastoma gene product regulates progression through G1 phase of the cell cycle. Cell 67, 293\u2013302 (1991).","journal-title":"Cell"},{"key":"BFng0898_371_CR13","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0092-8674(90)90251-9","volume":"62","author":"M Laiho","year":"1990","unstructured":"Laiho, M., DeCaprio, J.A., Ludlow, J.W., Livingston, D.M. & Massague, J. Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation. Cell 62, 175\u2013185 (1990).","journal-title":"Cell"},{"key":"BFng0898_371_CR14","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1099\/0022-1317-76-7-1815","volume":"76","author":"K Zerfass","year":"1995","unstructured":"Zerfass, K. et al. Cell cycle-dependent disruption of E2F-p107 complexes by human papillomavirus type 16 E7. J. Gen. Virol. 76, 1815\u2013 1820 (1995).","journal-title":"J. Gen. Virol"},{"key":"BFng0898_371_CR15","first-page":"5929","volume":"51","author":"AC Huggett","year":"1991","unstructured":"Huggett, A.C. et al. Development of resistance to the growth inhibitory effects of transforming growth factor beta 1 during the spontaneous transformation of rat liver epithelial cells. Cancer Res. 51, 5929\u2013 5936 (1991).","journal-title":"Cancer Res"},{"key":"BFng0898_371_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/(SICI)1097-0045(19970401)31:1<61::AID-PROS10>3.0.CO;2-M","volume":"31","author":"ER Barrack","year":"1997","unstructured":"Barrack, E.R. TGF-beta in prostate cancer: a growth inhibitor that can enhance tumorigenicity. Prostate 31, 61\u201370 ( 1997).","journal-title":"Prostate"},{"key":"BFng0898_371_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1359-6101(96)00050-0","volume":"8","author":"RW Padgett","year":"1997","unstructured":"Padgett, R.W., Savage, C. & Das, P. Genetic and biochemical analysis of TGF beta signal transduction. Cytokine Growth Factor Rev. 8, 1\u2013 9 (1997).","journal-title":"Growth Factor Rev"},{"key":"BFng0898_371_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1615\/CritRevOncog.v7.i1-2.20","volume":"7","author":"M Namba","year":"1996","unstructured":"Namba, M., Mihara, K. & Fushimi, K. Immortalization of human cells and its mechanisms. Crit. Rev. Oncog . 7, 19\u201331 ( 1996).","journal-title":"Crit. Rev. Oncog"},{"key":"BFng0898_371_CR19","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/334124a0","volume":"334","author":"P Whyte","year":"1988","unstructured":"Whyte, P. et al. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 334 , 124\u2013129 (1988).","journal-title":"Nature"},{"key":"BFng0898_371_CR20","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1126\/science.3823889","volume":"235","author":"W-H Lee","year":"1987","unstructured":"Lee, W.-H. et al. Human retinoblastoma susceptibility gene: cloning, identification and sequence . Science 235, 1394\u20131399 (1987).","journal-title":"Science"},{"key":"BFng0898_371_CR21","doi-asserted-by":"publisher","first-page":"6474","DOI":"10.1073\/pnas.86.17.6474","volume":"86","author":"R Bernards","year":"1989","unstructured":"Bernards, R. et al. Structure and expression of the murine retinoblastoma gene and characterization of its encoded protein. Proc. Natl Acad. Sci. USA 86 , 6474\u20136478 (1989).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFng0898_371_CR22","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1182\/blood.V91.6.1917","volume":"91","author":"E Bruno","year":"1998","unstructured":"Bruno, E. et al. The Smad5 gene is involved in the intracellular signaling pathways that mediate the inhibitory effects of transforming growth factor-beta on human hematopoiesis . Blood 91, 1917\u20131923 (1998).","journal-title":"Blood"},{"key":"BFng0898_371_CR23","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3109\/08977199109000263","volume":"4","author":"A Altiok","year":"1991","unstructured":"Altiok, A. Effect of transforming growth factor-beta 1 and -beta 2 on the proliferation of Burkitt lymphoma and lymphoblastoid cell lines. Growth Factors 4, 117\u2013128 (1991).","journal-title":"Growth Factors"},{"key":"BFng0898_371_CR24","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0147-0272(97)80003-7","volume":"21","author":"R Gryfe","year":"1997","unstructured":"Gryfe, R. et al. Molecular biology of colorectal cancer. Curr. Probl. Cancer 21, 233\u2013300 (1997).","journal-title":"Curr. Probl. Cancer"},{"key":"BFng0898_371_CR25","first-page":"460","volume":"76","author":"W Piacibello","year":"1991","unstructured":"Piacibello, W., Severino, A., Stacchini, A. & Aglietta, M. Differential effect of transforming growth factor beta 1 on the proliferation of human lymphoid and myeloid leukemia cells. Haematologica 76, 460\u2013466 (1991).","journal-title":"Haematologica"},{"key":"BFng0898_371_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/mc.2940010307","volume":"1","author":"S Garfield","year":"1988","unstructured":"Garfield, S., Huber, B.E., Nagy, P., Cordingley, M.G. & Thorgeirsson, S.S. Neoplastic transformation and lineage switching of rat liver epithelial cells by retrovirus-associated oncogenes. Mol. Carcinog. 1, 189\u2013195 (1988).","journal-title":"Mol. Carcinog"}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ng0898_371.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng0898_371","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ng0898_371.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T20:14:36Z","timestamp":1638389676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ng0898_371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,8]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1998,8]]}},"alternative-id":["BFng0898_371"],"URL":"https:\/\/doi.org\/10.1038\/1258","relation":{},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,8]]}}}